MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2016 International Congress

    Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia

    J. Jankovic, S. Marc, A. Aubrey (Houston, TX, USA)

    Objective: Data from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy), an observational, multicenter, prospective clinical registry, were analyzed to try to…
  • 2016 International Congress

    Clinical characteristics and natural history of oromandibular dystonia

    L. Scorr, S. Factor, H. Jinnah (Atlanta, GA, USA)

    Objective: The overall goal of this study is to better define the clinical characteristics and natural history of oromandibular dystonia (OMD). Background: OMD is a…
  • 2016 International Congress

    Assessing vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment

    K.L. Andrzejewski, A. Owens, M.T. Bull, K.M. Biglan, S. Kanchana, J.W. Mink, R. Barbano (Rochester, NY, USA)

    Objective: To determine if individuals with cervical dystonia have altered vestibular function compared to unaffected individuals, and whether botulinum toxin treatment alters those variables. Background:…
  • 2016 International Congress

    Clinical profile of patients with writer’s cramp

    H.S. Kaleagasi, O. Dogu (Mersin, Turkey)

    Objective: To present the clinical profile of 16 patients with simple writer's cramp who were treated with botulinum toxin injections. Background: Writer's cramp is the…
  • 2016 International Congress

    Epidemiological and clinical profile of essential blepharospasm and its response to treatment with TBA over a 11-year period

    J.R.R. Manoel, U.C. Júnior, D.P. Nones, F.M.B. Germiniani, H.A.G. Teive (Curitiba, Brazil)

    Objective: To report the epidemiological and clinical profile of patients with essential bleaphrospasm from the outpatient clinic of Movement Disorders of the Hospital de Clínicas…
  • 2016 International Congress

    Synergistic effects of physical therapy and botulinum toxin in primary cervical dystonia

    W. Hu, V. Rundle-Gonzalez, S.J. Kulkarni, L. Almeida, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To compare standard botulinum toxin (BoNT) versus physical therapy (PT) combined with BoNT in primary cervical dystonia (PCD). Background: PCD is frequently a source…
  • 2016 International Congress

    Pilot study on the long lasting effectivness of an integrated tailored sensory-motor rehabilitation program associated with BoNTA in cervical dystonia

    A. Castagna, M. Ramella, A. Crippa, L. Sciumè, G. Giacobbi, C. Corrini, D. Anastasi, A. Montesano (Milano, Italy)

    Objective: The aim of this study is to assess the long lasting effectiveness of an integrated tailored sensory-motor rehabilitation program (TsmRP) associated with botulinum toxin…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley